Investing12d
Illumina’s SWOT analysis: next-gen sequencing leader faces headwinds
Additionally, the long-read sequencing market ... instrument sales and higher consumables pull-through. Illumina’s introduction of the MiSeq i100 series demonstrates the company’s commitment ...
Investing12d
Illumina’s SWOT analysis: next-gen sequencing leader faces headwinds
Illumina has established a strong foothold in the market. The company’s product portfolio includes high-throughput sequencers like the NovaSeq X series, as well as lower-throughput instruments such as ...
San Diego Union-Tribune21d
Illumina cuts workforce at San Diego headquarters
Over the past year, the shadow of the Grail deal has hung over Illumina despite its reinvigorated leadership and launch of new partnerships or products, namely the MiSeq i100 benchtop sequencer.
Le Lézard18d
Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year
Illumina, Inc. , a global leader in DNA sequencing and array-based technologies, has been named for the sixth year in a row to the Dow Jones Best-in-Class World Index and the Dow Jones Best-in-Class ...
Nasdaq18d
Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year
SAN DIEGO, March 6, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array ... in 2024 with the launch of the MiSeq i100 Series, which included key ...
Case Western Reserve University27d
Next Generation Sequencing Services
The MiSeq desktop sequencer offers low throughput flowcells and long read lengths. It is best for small whole-genome sequencing, targeted gene sequencing, metagenomics, and CRISPR validation. The ...
Case Western Reserve University28d
Our Services
The Genomics Core offers a wide range of genomic and DNA/RNA services. We operate the Illumina NovaSeq X Plus, NextSeq 550, and MiSeq platforms for all Next Generation Sequencing and offer an ...
FMIBlog6d
Global Life Science and Chemical Instruments Market Poised for Significant Growth USD 79.7 Billion by 2034 Grow at 5.3% CAGR | FMI
The global life science and chemical instruments market is set to witness remarkable expansion, reaching an estimated value of USD 47.5 billion in 2024. With a steady compound annual growth rate (CAGR ...